DERMAGRAFT (HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE)

FDA Premarket Approval P000036 S017

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Qualification of additional seeding vessels, and proposed a change in the type of material used for the tubing and manifold assembly connector fittings.

DeviceDERMAGRAFT (HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE)
Generic NameDressing, Wound And Burn, Interactive
ApplicantSHIRE REGENERATIVE MEDICINE
Date Received2013-04-24
Decision Date2013-05-23
PMAP000036
SupplementS017
Product CodeMGR 
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address SHIRE REGENERATIVE MEDICINE 11095 Torreyana Road san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P000036Original Filing
S018 2013-04-25 30-day Notice
S017 2013-04-24 30-day Notice
S016 2013-04-23 30-day Notice
S015
S014 2012-12-21 135 Review Track For 30-day Notice
S013 2012-06-29 30-day Notice
S012 2012-06-05 30-day Notice
S011 2012-04-23 135 Review Track For 30-day Notice
S010 2012-03-16 30-day Notice
S009 2012-03-16 30-day Notice
S008 2012-03-13 Normal 180 Day Track No User Fee
S007 2010-03-02 30-day Notice
S006 2008-10-31 30-day Notice
S005
S004
S003 2003-11-17 Special (immediate Track)
S002 2002-03-05 Special (immediate Track)
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.